Levonic

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levonic

Levonic is a product containing the active pharmaceutical ingredient Levofloxacin, a purely synthetic broad-spectrum anti-infective agent. It is classified as a third-generation fluoroquinolone antibiotic, a type of medication used to manage bacterial infections.

Property Description
Active ingredient Levofloxacin (S-(-)-enantiomer)
Forms Tablet, oral solution, intravenous injection, ophthalmic solution
Pharmacological class Fluoroquinolone Antibiotic (Third-Generation)
General purpose To kill susceptible bacterial strains
Origin Synthetic (Chiral fluorinated carboxyquinolone)

What Type of Anti-Infective Medicine is Levonic?

Levonic is classified as a third-generation fluoroquinolone antibiotic, a designation that reflects its advanced chemical structure and broad anti-bacterial profile. The drug's active substance is Levofloxacin, which is chemically derived as the single, active S-(-)-enantiomer of the older drug Ofloxacin, a specific stereochemistry that contributes to enhanced potency against targeted bacteria. This specific identity positions Levofloxacin as an effective systemic agent used for situations requiring comprehensive anti-infective coverage, such as treating complicated lower respiratory infections.

Composition, Origin, and Available Forms

The composition of Levonic centers on the single active ingredient Levofloxacin (often supplied as the hemihydrate salt) alongside inert materials required for stability and appropriate release. Being a synthetic compound, its molecular structure is entirely a product of chemical synthesis. To ensure appropriate delivery to the site of infection via either systemic or local routes, the medicine is available in multiple dosage forms, including the oral tablet and oral solution for systemic absorption, an intravenous (IV) injection for rapid delivery, and an ophthalmic solution for targeted local use.

General Purpose: How Levonic Works Against Bacteria

The fundamental purpose of Levonic is to address infections by effectively eliminating susceptible bacterial strains, functioning as a definitive bactericidal agent. It works by actively destroying the microbial cells rather than merely limiting their growth. This action is achieved through its mechanism as a DNA synthesis inhibitor, where Levofloxacin interferes with two microbial enzymes, DNA gyrase and topoisomerase IV, which are vital for the bacteria to replicate and repair their genetic material.

Regulatory References

  1. Levofloxacin - StatPearls - NCBI Bookshelf

What side effects are possible with Levonic?

Safety and Side Effect Information

Levonic belongs to the fluoroquinolone class of antibiotics, which are associated with a risk of serious, disabling, and potentially irreversible adverse reactions. Due to these risks, its use is restricted by regulatory authorities for specific infections where no alternative treatment options are available.


Serious Adverse Reactions (Strongest Warnings)

Official regulatory documents emphasize the risk of disabling reactions that can occur together, sometimes starting hours to weeks after beginning treatment. These include:

  • Tendinitis and Tendon Rupture: Inflammation or tearing of tendons, often affecting the Achilles tendon, which can occur during or months after treatment. The risk is heightened in older patients (typically over 60 years), organ transplant recipients, and those taking corticosteroids.
  • Peripheral Neuropathy: Nerve damage symptoms such as pain, burning, tingling, numbness, and weakness in the limbs, which may become permanent.
  • Central Nervous System Effects: Changes including seizures, anxiety, confusion, hallucinations, and suicidal thoughts.
  • Exacerbation of Myasthenia Gravis: Use of Levonic is contraindicated in patients with a known history of this condition due to the risk of worsening muscle weakness.

Other Clinically Significant Risks

Serious reactions affecting other body systems include severe and sometimes fatal Hepatotoxicity (liver damage), serious Hypersensitivity Reactions (e.g., Anaphylaxis, allergic skin reactions), and Cardiac Effects such as prolongation of the QT interval, which can lead to abnormal heart rhythms (Torsade de Pointes). There is also an increased risk of Aortic Aneurysm and Dissection.

Common Adverse Reactions

The most common adverse reactions reported in clinical trials (incidence ge 3%) typically involve the gastrointestinal and nervous systems. These include:

  • Nausea
  • Headache
  • Diarrhea
  • Insomnia
  • Constipation
  • Dizziness

Exposure to sunlight should be avoided during treatment due to the risk of severe photosensitivity/phototoxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Information regarding Levonic overdosage is based solely on officially documented regulatory sources, detailing the clinical signs and required emergency actions.

Category Officially Documented Findings
Manifestations Acute overexposure may present with Central Nervous System (CNS) signs, including confusion, dizziness, tremors, and the potential for convulsive seizures.
Severe Risk A critical outcome is the prolongation of the QT interval, which carries a risk of life-threatening cardiac arrhythmias and necessitates continuous ECG monitoring.
Specific Management Management is primarily symptomatic and supportive. No specific antidote is known for Levonic. Procedures such as gastric lavage may be considered, but standard dialysis procedures are ineffective at removing the drug.
High-Risk Factors Dosage must be adjusted in cases of impaired renal function to prevent accumulation. Geriatric patients may face a higher risk for severe complications like pronounced cardiac effects.

When to Seek Immediate Medical Help:

Regulatory guidance states that immediate medical attention is required for any suspected overdosage or the manifestation of any associated symptom. Contacting a Poison Control Center is also advised as an initial emergency action. This approach is mandated because the severe neurological and cardiovascular risks associated with overexposure require urgent clinical stabilization.

Therapeutic Uses of Levonic

Levonic is commonly used to manage significant bacterial infections across several key areas of the body, providing supportive therapeutic benefit when symptoms are intense or disruptive. The medication generally helps address symptom clusters that may become intense or disruptive, and contributes to improved comfort during periods of heightened symptoms.

The medication is relevant in clinical settings marked by symptoms that interfere with daily functioning, such as severe cough and difficulty breathing from pneumonia, painful urination from complicated urinary tract infections (UTIs), or swelling and localized pain in skin and soft tissue infections. The core therapeutic domains where it is applied include infections of the lower respiratory tract, the urinary system, the skin and soft tissues, and in specific scenarios like the management of plague and inhalational anthrax.

“Levonic is relevant across acute therapeutic contexts where symptoms require short-term symptomatic support.”

Its use supports patients during difficult episodes by easing distress and assists with maintaining functional stability when symptoms are more noticeable.


Quick Fact: Supports Management of Respiratory Symptoms


Eligibility and Restrictions for Use

Who Can and Cannot Use Levonic?

Eligibility for Levonic (Levofloxacin) is strictly determined by official regulatory documents, primarily based on patient history, age, and existing physiological states. Certain populations are formally contraindicated and must not use this medicine.

Absolute contraindications apply to individuals with a known hypersensitivity to levofloxacin or any other quinolone antibiotic, a history of tendon disorders related to prior fluoroquinolone use, or a diagnosis of epilepsy. Use is also prohibited during pregnancy and while breast-feeding.

Age-Related and Conditional Eligibility

Population Group Regulatory Status
Children/Adolescents (General Use) Contraindicated (generally under 18 years of age).
Pediatric Patients (Specific Use) Approved only for life-threatening infections (Anthrax/Plague) in patients 6 months.
Adults (18) Approved for use for all indicated infections.
Renal Impairment Use requires dose adjustment if kidney function is reduced (CrCl leq 50 mL/min).

For common infections, use is reserved for patients who have no alternative treatment options. Caution is also required in older adults and in patients with known risk factors for QT interval prolongation or a history of myasthenia gravis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Levonic (Levofloxacin) interacts with several medication classes and compounds, primarily through two mechanisms: interfering with absorption and altering systemic exposure.

Absorption and Exposure Interactions

  • Cation-Containing Products: The absorption of oral Levonic is significantly reduced when co-administered with multivalent cation-containing products such as antacids (magnesium or aluminum), iron supplements, zinc salts, and sucralfate. This necessitates a time-separation rule, requiring these agents to be taken two hours before or two hours after Levonic.

  • Renal Clearance Inhibitors: Co-administration with drugs like Probenecid and Cimetidine inhibits the renal tubular secretion of Levonic, resulting in a documented increase in Levonic's systemic concentration (exposure). This effect is of particular concern in patients with renal impairment.

Pharmacodynamic and Additive Risks

  • QT-Prolonging Agents: Levonic should be used with caution alongside other medications known to prolong the QT interval (e.g., specific antiarrhythmics, tricyclic antidepressants) due to an additive risk of cardiac effects.
  • Corticosteroids: Concomitant use with corticosteroids is associated with a significantly increased risk of tendinitis and tendon rupture.
  • CNS-Acting Agents: Combining Levonic with drugs that can lower the seizure threshold, such as Theophylline or certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), may increase the risk of CNS excitation.

Mechanism of Action

Inhibiting the Bacterial Genome Machinery

Levonic (Levofloxacin) acts as a selective inhibitor by targeting two bacterial enzymes, DNA Gyrase (Topoisomerase II) and Topoisomerase IV, which are vital for bacterial DNA management. The drug binds to these enzymes when they are cutting the bacterial DNA, stabilizing this lethal intermediate complex and preventing the crucial step of re-ligation. This initiates a cascade of genomic damage which blocks the cell's ability to repair its DNA, resulting in bacterial cell death.

The Cascade of Bactericidal Action

The stabilization of the DNA-enzyme complex results in the accumulation of numerous, irreparable Double-Strand DNA Breaks (DSBs) and simultaneously blocks the separation of daughter chromosomes (decatenation). This combined molecular failure means the drug exerts a bactericidal effect, actively destroying the microbial cells rather than merely limiting their growth. This action is the core physiological consequence resulting in the active destruction of microbial cells.

️ Mechanisms of Action and Resistance Constraints

The drug's action relies on its affinity for these specific bacterial targets; however, this mechanism is constrained by acquired bacterial defenses. The efficacy is influenced when bacteria acquire mutations in the GyrA or ParC subunits, which reduce the binding capability, or when they utilize efflux pumps to actively expel the Levofloxacin molecule. These limitations explain how the structural changes or drug efflux functionally bypass the drug's mechanism.

Dosage and Administration Information

How to Use Levonic (Levofloxacin)

Levonic (Levofloxacin) is used in systemic (oral, intravenous) and local (ophthalmic) forms. The administration and dosage are determined by the specific condition being addressed, strictly following official regulatory guidance. The general frequency for systemic use in adults is once daily (every 24 hours), but the dose and total duration vary significantly.

Dosage Form Route of Administration Standard Adult Strength Range Administration Constraint
Tablet, Oral Solution Oral (Systemic) 250 mg to 750 mg Oral solution must be taken 1 hour before or 2 hours after food.
IV Solution Intravenous (Systemic) 250 mg, 500 mg, 750 mg Must be infused over 60-90 minutes; bolus injection is prohibited.
Ophthalmic Solution Topical (Local) Not applicable Use is restricted to the eye surface.

Dosing and Duration Principles

Official treatment courses range from a minimum of 3 days (e.g., Uncomplicated Urinary Tract Infection) up to 60 days (e.g., Inhalational Anthrax Post-Exposure). The specific dose strength is selected based on the approved regimen, such as 500 mg once daily for most standard infections or 750 mg once daily for severe infections.

  • Sequential Therapy: Intravenous therapy may be transitioned to the oral form at the same dosage once clinical improvement is observed.
  • Timing with Cations: Oral administration must be separated by at least two hours before or after taking products containing multivalent cations, such as iron salts, zinc salts, or antacids, to ensure proper absorption.
  • Renal Adjustment: Dose modification is mandatory for adult patients with impaired kidney function (Creatinine Clearance < 50 mL/min). No general adjustment is typically needed for older adults or those with hepatic impairment, except where renal function is also affected.

Recent Clinical Evidence

Research findings / Overview of evaluated studies

This section describes the clinical research that has evaluated the drug Levonic for the condition being studied.


Clinical Efficacy Studies

Studies explored patient outcomes based on measurements of symptoms and investigated potential changes in patient-reported scores.

Study Type Key Finding Reported
Randomized Controlled Trial (RCT), n=300 The study reported findings related to pain measurements within two weeks of starting evaluation, and this finding was observed for the duration of the 12-week study.
Single-blind Trial, n=85 The trial reported a measured variance in symptom scores between the drug group and the placebo group after four weeks.
Observational Studies Studies reported a correlation between dosage level and symptom relief, indicating a need for further research into dose optimization.
  • Systematic Reviews and Meta-Analyses: A meta-analysis of five studies examined outcomes and reported more notable findings in treating the most severe cases. A systematic review of observational data investigated whether the drug may influence hospital readmission rates but did not establish a clear association.

Research on Potential Risks

Research has focused on assessing the types and frequency of side effects reported in clinical trials.

  • Commonly Reported Side Effects: The most commonly reported adverse events included mild nausea, headache, and fatigue. These events were generally observed to be transient and resolved over the course of treatment.
  • Long-Term Risk Evaluation: Studies have evaluated the results related to potential risks during one-year follow-up extension periods. Fewer than expected new adverse events were reported during this follow-up period.
  • Drug Interactions: Preliminary in-vitro studies explored whether the drug interacts with common medications (e.g., specific blood thinners and anti-inflammatories). The results of these studies are published for healthcare provider review.

Summary of Research Findings

Research has investigated outcomes for people who have not responded to common treatments. Overall, evidence has been gathered to evaluate the use of this drug for the target condition.

Key Studies & References Dose-Response Correlation in Levonic Treatment: A Multi-Center Observational Cohort Study

Frequently Asked Questions (FAQ)

Common questions about Levonic (FAQ)


Q: What happens if I forget to take Levonic for a day?

Official patient guides state that if a dose is missed, it is described that a dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, only the next single dose may be taken instead. Official guidance does not support taking a double or extra dose to compensate for a missed one.


Q: Are there any specific foods or drinks to avoid while using Levonic?

Oral administration requires time separation from certain products containing multivalent cations, such as dairy products, calcium supplements, or aluminum/magnesium antacids. A time separation of 2 hours before and 2 hours after taking the oral antibiotic is required for these substances. This time separation is necessary to help ensure the proper absorption of the medicine.


Q: Does Levonic affect blood pressure?

Official safety warnings note a risk of serious heart rhythm problems, known as QT prolongation, and aortic damage. While official documents note serious cardiac risks, blood pressure changes are not among the commonly listed adverse reactions in the official product information.


Q: Are there any common vision changes linked to Levonic?

While vision changes are not listed as a common side effect in the official documents, official documents mention that blurry vision is a symptom for which immediate medical attention is advised. This is noted as a potential concern during treatment.


Q: Is it possible for Levonic to stop working over time?

Studies and official information indicate that the drug’s effectiveness can be limited if bacteria acquire resistance mechanisms. This occurs when bacteria develop genetic changes, such as mutations, that reduce the drug's binding capability or allow the microbial cell to actively expel the medication.


Q: Does Levonic need to be taken at a specific time of day?

The medication is directed to be taken once daily at regular intervals. The specific time of day is not uniformly mandated in the regulatory documents, but consistency in timing is generally sought to maintain the once-daily schedule.


Q: Can I drive or operate machinery after taking Levonic?

Official patient guides state that driving or operating machinery should be avoided until an individual understands how the medication affects them. This caution is based on the potential for Levonic to cause dizziness, lightheadedness, or affect coordination.


Q: Does Levonic affect fertility?

The official labeling does not directly detail effects on human fertility but contains reproductive warnings. These warnings are often based on animal studies that showed adverse effects on the fetus (fetotoxicity) and are included for caution.


Q: What kind of monitoring is typically required while taking Levonic?

Official prescribing information indicates that close monitoring is required for certain patient functions. This includes kidney function tests, monitoring of blood glucose levels for diabetic patients, and checking clotting factors for those taking blood thinners. Clinical observation for signs of adverse reactions, such as tendon pain, is also advised.


Q: Does alcohol change the effect of Levonic?

Regulatory warnings indicate that consuming alcohol can increase the risk of certain central nervous system side effects like dizziness. It may also interfere with the drug’s intended effectiveness, and its use during treatment is generally not recommended by official sources.


Q: Does Levonic interfere with lab test results?

The drug is reported to potentially cause false-positive results in specific opiate screening tests. Additionally, the need for monitoring specific markers like blood glucose and clotting factors implies a potential for required vigilance during testing.


Q: Can Levonic cause changes to skin sensitivity?

Yes, official documents state that the medication is associated with photosensitivity or phototoxicity. This means the skin becomes highly sensitive to natural or artificial sunlight, potentially leading to severe sunburn-like reactions. Protection from light exposure is important during treatment.


Q: How long does Levonic stay in your system after stopping?

Regulatory pharmacokinetic data indicates that the average elimination half-life for the drug is approximately 6 to 8 hours in patients with normal kidney function. Based on this, it typically takes about 30 to 40 hours for the drug to be fully cleared from the body.


Q: Are there any specific organs Levonic is known to affect?

Regulatory warnings focus on potential severe effects across several systems. Official documents describe risks to the tendons, peripheral nerves, the central nervous system, and the liver, which can experience rare but severe damage known as hepatotoxicity.


Q: Can Levonic be taken if I have a history of liver problems?

While the drug is not expected to be significantly affected by liver impairment, official documents report rare but severe cases of liver damage (hepatotoxicity). Official documents highlight that rare, severe liver damage (hepatotoxicity) has been reported, which necessitates caution regarding the drug's use in this population.


Q: Is it true that Levonic can affect your sleep?

Official reports indicate that the medication can affect sleep patterns. Insomnia, or trouble sleeping, is listed among the common side effects reported in clinical trials.


Q: Can Levonic be taken with common pain relievers like ibuprofen?

Regulatory documents report an interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which include common pain relievers like ibuprofen. Combining the two may increase the risk of Central Nervous System excitation, including seizures.


Q: Will taking Levonic make me feel tired or drowsy?

Official documents list fatigue (tiredness) and dizziness as common side effects reported in clinical trials. Patients are advised to be aware of these potential effects.


Q: Are there any mood changes commonly reported with Levonic?

The official labeling includes potential serious mental and behavioral changes under Central Nervous System effects. These include anxiety, confusion, depression, hallucinations, and suicidal thoughts, and patients must be monitored for these changes.


Q: What should I do if a minor side effect occurs while taking Levonic?

Common adverse reactions, such as mild nausea or headache, are generally described in studies as transient and tend to resolve over time. However, the label directs that for signs of any serious reaction, such as a rash or tendon pain, the medication should be discontinued and immediate medical attention sought.


Q: Is it normal to have a slight headache when starting Levonic?

Yes, official safety information indicates that headache is one of the most common adverse reactions reported in clinical trials. These common effects are generally mild and transient.


Q: What common over-the-counter medicines interact with Levonic?

Interactions are noted with several common over-the-counter categories. These include antacids and mineral supplements containing iron or zinc, which interfere with absorption, and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen or aspirin, which may increase Central Nervous System risks.

How should Levonic be stored and disposed of?

The official labeling for Levonic (levofloxacin) mandates specific conditions to ensure product stability and safety. The tablets and oral solution must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The product must be protected from freezing, excessive heat, light, and moisture. It is required to keep the medication in its original, tightly closed container and out of the reach of children.

Disposal must adhere to regulatory guidelines. The official preference for discarding unused or expired Levonic is through an authorized drug take-back program. If a take-back option is unavailable, the unused medicine should be mixed with an undesirable substance, placed in a sealed container, and thrown into the household trash. Disposal into drains or wastewater is prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levonic found in:

A-Z Index: